View Item 

Show simple item record

The future of cancer screening after COVID‐19 may be at home
dc.contributor.authorGorin, Sherri N. Sheinfeld
dc.contributor.authorJimbo, Masahito
dc.contributor.authorHeizelman, Robert
dc.contributor.authorHarmes, Kathryn M.
dc.contributor.authorHarper, Diane M.
dc.date.accessioned2021-02-04T21:51:29Z
dc.date.available2022-03-04 16:51:28en
dc.date.available2021-02-04T21:51:29Z
dc.date.issued2021-02-15
dc.identifier.citationGorin, Sherri N. Sheinfeld; Jimbo, Masahito; Heizelman, Robert; Harmes, Kathryn M.; Harper, Diane M. (2021). "The future of cancer screening after COVID‐19 may be at home." Cancer 127(4): 498-503.
dc.identifier.issn0008-543X
dc.identifier.issn1097-0142
dc.identifier.urihttps://hdl.handle.net/2027.42/166218
dc.publisherWiley Periodicals, Inc.
dc.subject.otherbreast
dc.subject.otherscreening
dc.subject.othercancer
dc.subject.otherhome
dc.subject.otherCOVID‐19
dc.subject.othercolorectal
dc.subject.othercervical
dc.titleThe future of cancer screening after COVID‐19 may be at home
dc.typeArticle
dc.rights.robotsIndexNoFollow
dc.subject.hlbsecondlevelPublic Health
dc.subject.hlbsecondlevelOncology and Hematology
dc.subject.hlbtoplevelHealth Sciences
dc.description.peerreviewedPeer Reviewed
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/166218/1/cncr33274.pdf
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/166218/2/cncr33274_am.pdf
dc.identifier.doi10.1002/cncr.33274
dc.identifier.doihttps://dx.doi.org/10.7302/141
dc.identifier.sourceCancer
dc.identifier.citedreferencePaxton A. For one laboratory, a workflow transformation. Published June 2018. Accessed June 2, 2020. https://www.captodayonline.com/one‐laboratory‐workflow‐transformation/
dc.identifier.citedreferenceDatta GD, Mayrand MH, Qureshi S, Ferre N, Gauvin L. HPV sampling options for cervical cancer screening: preferences of urban‐dwelling Canadians in a changing paradigm. Curr Oncol. 2020; 27: e171 ‐ e181.
dc.identifier.citedreferenceHermansson RS, Olovsson M, Gustavsson C, Lindstrom AK. Elderly women’s experiences of self‐sampling for HPV testing. BMC Cancer. 2020; 20: 473.
dc.identifier.citedreferenceJede F, Brandt T, Gedefaw M, et al. Home‐based HPV self‐sampling assisted by a cloud‐based electronic data system: lessons learnt from a pilot community cervical cancer screening campaign in rural Ethiopia. Papillomavirus Res. 2020; 9: 100198.
dc.identifier.citedreferencePimple SA, Mishra GA, Deodhar KK. Evidence based appropriate triage strategies for implementing high risk HPV as primary technology in cervical cancer screening. Minerva Ginecol. 2020; 72: 96 ‐ 105.
dc.identifier.citedreferenceDavies R, Miller R, Coleman N. Colorectal cancer screening: prospects for molecular stool analysis. Nat Rev Cancer. 2005; 5: 199 ‐ 209.
dc.identifier.citedreferenceSimon K. Colorectal cancer development and advances in screening. Clin Interv Aging. 2016; 11: 967 ‐ 976.
dc.identifier.citedreferenceUS Preventive Services Task Force, Bibbins‐Domingo K, Grossman DC, et al. Screening for colorectal cancer: US Preventive Services Task Force recommendation statement. JAMA. 2016; 315: 2564 ‐ 2575.
dc.identifier.citedreferenceOuyang DL, Chen JJ, Getzenberg RH, Schoen RE. Noninvasive testing for colorectal cancer: a review. Am J Gastroenterol. 2005; 100: 1393 ‐ 1403.
dc.identifier.citedreferenceUS Food and Drug Administration. Self‐collection devices for Pap test: FDA public workshop. Published January 11, 2018. Accessed June 2, 2020. https://www.fda.gov/media/110292/download
dc.identifier.citedreferenceBuist DSM, Tiro JA, Thayer C, et al. Improving the promise of embedded pragmatic trials: surmountable barriers encountered in an evaluation of home‐based HPV self‐sampling to increase cervical cancer screening in overdue women. Contemp Clin Trials Commun. 2019; 15: 100413.
dc.identifier.citedreferenceTiro JA, Betts AC, Kimbel K, et al. Understanding patients’ perspectives and information needs following a positive home human papillomavirus self‐sampling kit result. J Womens Health (Larchmt). 2019; 28: 384 ‐ 392.
dc.identifier.citedreferenceWiner RL, Lin J, Tiro JA, et al. Effect of mailed human papillomavirus test kits vs usual care reminders on cervical cancer screening uptake, precancer detection, and treatment: a randomized clinical trial. JAMA Netw Open. 2019; 2: e1914729.
dc.identifier.citedreferenceHealth Center Network New York. EHR best practice workflow and documentation guide to support colorectal cancer screening improvement in eClinicalWorks. Accessed June 2, 2020. http://nccrt.org/wp‐content/uploads/CRC‐Screening‐eCW‐Best‐Practices‐Guide‐HCNNY‐112015.pdf
dc.identifier.citedreferenceBacolod MD, Huang J, Giardina SF, et al. Prediction of blood‐based biomarkers and subsequent design of bisulfite PCR‐LDR‐qPCR assay for breast cancer detection. BMC Cancer. 2020; 20: 85.
dc.identifier.citedreferenceMehrotra A, Chernew M, Linetsky D, Hatch H, Cutler D, Schneider EC. The impact of the COVID‐19 pandemic on outpatient visits: changing patterns of care in the newest COVID‐19 hot spots. Published August 13, 2020. Accessed September 24, 2020. https://www.commonwealthfund.org/publications/2020/aug/impact‐covid‐19‐pandemic‐outpatient‐visits‐changing‐patterns‐care‐newest
dc.identifier.citedreferenceNPR, Robert Wood Johnson Foundation. Harvard T.H. Chan School of Public Health survey. The Impact of Coronavirus on Households in Rural America. Accessed October 18, 2020. https://cdn1.sph.harvard.edu/wp‐content/uploads/sites/94/2020/10/Rural‐Report_100520‐FINAL.pdf
dc.identifier.citedreference174 Rural Hospital Closures: January 2005 – Present (132 since 2010). Accessed October 18, 2020. https://www.shepscenter.unc.edu/programs‐projects/rural‐health/rural‐hospital‐closures/
dc.identifier.citedreferenceWeiser E, Parks PD, Swartz RK, et al. Cross‐sectional adherence with the multi‐target stool DNA test for colorectal cancer screening: real‐world data from a large cohort of older adults. J Med Screen. 2020 Feb 13:969141320903756. doi: 10.1177/0969141320903756
dc.identifier.citedreferenceKlabunde CN, Lanier D, Nadel MR, McLeod C, Yuan G, Vernon SW. Colorectal cancer screening by primary care physicians: recommendations and practices, 2006‐2007. Am J Prev Med. 2009; 37: 8 ‐ 16.
dc.identifier.citedreferenceMcQueen A, Bartholomew LK, Greisinger AJ, et al. Behind closed doors: physician‐patient discussions about colorectal cancer screening. J Gen Intern Med. 2009; 24: 1228 ‐ 1235.
dc.identifier.citedreferenceHawley S, Lillie S, Cooper G, Elston Lafata J. Managed care patients’ preferences, physician recommendations, and colon cancer screening. Am J Manag Care. 2014; 20: 555 ‐ 561.
dc.identifier.citedreferenceCommunity Preventive Services Task Force. All Active Recommendations September 2020. Accessed September 11, 2020. https://www.thecommunityguide.org/sites/default/files/assets/CPSTF‐Recommendations‐508.pdf
dc.identifier.citedreferencePeintinger F. National breast screening programs across Europe. Breast Care (Basel). 2019; 14: 354 ‐ 358. doi: 10.1159/000503715
dc.identifier.citedreferenceKoo S, Neilson LJ, Von Wagner C, Rees CJ. The NHS Bowel Cancer Screening Program: current perspectives on strategies for improvement. Risk Manag Healthc Policy. 2017; 10: 177 ‐ 187.
dc.identifier.citedreferenceEriksson EM, Lau M, Jonsson C, et al. Participation in a Swedish cervical cancer screening program among women with psychiatric diagnoses: a population‐based cohort study. BMC Public Health. 2019; 19: 313. doi: 10.1186/s12889‐019‐6626‐3
dc.identifier.citedreferenceAmerican Cancer Society. Common questions about the new coronavirus outbreak. Accessed April 26, 2020. https://www.cancer.org/latest‐news/common‐questions‐about‐the‐new‐coronavirus‐outbreak.html
dc.identifier.citedreferenceAmerican Society of Clinical Oncology. Cancer screening, diagnosis, staging and surveillance. Accessed April 26, 2020. https://www.asco.org/asco‐coronavirus‐resources/care‐individuals‐cancer‐during‐covid‐19/cancer‐screening‐diagnosis‐staging
dc.identifier.citedreferenceAmerican Society for Colposcopy and Cervical Pathology. Interim guidance for timing of diagnostic and treatment procedures for patients with abnormal cervical screening tests. Site updated March 19, 2020. Accessed April 28, 2020. https://www.asccp.org/covid‐198
dc.identifier.citedreferenceThe American Society of Breast Surgeons. ASBrS and ACR Joint Statement on Breast Screening Exams During the COVID‐19 Pandemic. Site updated March 26, 2020. Accessed April 28, 2020. https://www.breastsurgeons.org/news/?id=45
dc.identifier.citedreferenceNational Cancer Institute. Cancer Trends Progress Report. Online Summary of Trends in US Cancer Control Measures Centers for Disease Control and Prevention: colorectal cancer screening. Accessed June 2, 2020. https://progressreport.cancer.gov/detection/colorectal_cancer
dc.identifier.citedreferenceNational Cancer Institute. Cancer Trends Progress Report. Online Summary of Trends in US Cancer Control Measures Centers for Disease Control and Prevention: cervical cancer screening. Accessed June 2, 2020. https://progressreport.cancer.gov/detection/cervical_cancer
dc.identifier.citedreferenceNational Cancer Institute. Cancer Trends Progress Report. Online Summary of Trends in US Cancer Control Measures Centers for Disease Control and Prevention: breast cancer screening. Accessed June 2, 2020. https://progressreport.cancer.gov/detection/breast_cancer
dc.identifier.citedreferenceEPIC Health Research Network (EHRN). Preventive cancer screenings during COVID‐19 pandemic. Published May 2020. Accessed June 12, 2020. https://ehrn.org/wp‐content/uploads/Preventive‐Cancer‐Screenings‐during‐COVID‐19‐Pandemic.pdf
dc.identifier.citedreferenceIQVIA Institute for Human Data Science. Three months of COVID‐19 may mean 80,000 missed cancer diagnoses. Accessed June 12, 2020. https://www.medscape.com/viewarticle/929986
dc.identifier.citedreferenceWernli KJ, Hubbard RA, Johnson E, et al. Patterns of colorectal cancer screening uptake in newly eligible men and women. Cancer Epidemiol Biomarkers Prev. 2014; 23: 1230 ‐ 1237.
dc.identifier.citedreferenceUS Preventive Services Task Force. Colorectal cancer: screening. Accessed April 25, 2020. https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/colorectal‐cancer‐screening
dc.identifier.citedreferenceKim JJ, Burger EA, Regan C, Sy S. Screening for cervical cancer in primary care: a decision analysis for the US Preventive Services Task Force. JAMA. 2018; 320: 706 ‐ 714.
dc.identifier.citedreferenceUS Preventive Services Task Force. Final recommendation statement. Cervical cancer: screening. Accessed April 25, 2020. https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/cervical‐cancer‐screening
dc.identifier.citedreferenceUS Preventive Services Task Force. Final recommendation statement. Breast cancer: screening. Accessed April 25, 2020. https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/breast‐cancer‐screening
dc.identifier.citedreferenceKnudsen AB, Zauber AG, Rutter CM, et al. Estimation of benefits, burden, and harms of colorectal cancer screening strategies: modeling study for the US Preventive Services Task Force. JAMA. 2016; 315: 2595 ‐ 2609. doi: 10.1001/jama.2016.682816
dc.identifier.citedreferenceMartin K, Kurowski D, Given P, Kennedy K, Clayton E. Health Care Cost Institute. The Impact of COVID‐19 on the Use of Preventive Health Care. Accessed October 15, 2020. https://healthcostinstitute.org/hcci‐research/the‐impact‐of‐covid‐19‐on‐the‐use‐of‐preventive‐health‐care
dc.identifier.citedreferenceHaas CB, Phipps AI, Hajat A, Chubak J, Wernli KJ. Time to fecal immunochemical test completion for colorectal cancer screening. Am J Manag Care. 2019; 25: 174 ‐ 180.
dc.identifier.citedreferenceCaleia AI, Pires C, Pereira JF, Pinto‐Ribeiro F, Longatto‐Filho A. Self‐sampling as a plausible alternative to screen cervical cancer precursor lesions in a population with low adherence to screening: a systematic review. Acta Cytol. 2020; 64: 332 ‐ 343.
dc.identifier.citedreferenceImperiale TF, Ransohoff DF, Itzkowitz SH, et al. Multitarget stool DNA testing for colorectal‐cancer screening. N Engl J Med. 2014; 370: 1287 ‐ 1297.
dc.identifier.citedreferenceKisiel JB, Yab TC, Nazer Hussain FT, et al. Stool DNA testing for the detection of colorectal neoplasia in patients with inflammatory bowel disease. Aliment Pharmacol Ther. 2013; 37: 546 ‐ 554.
dc.identifier.citedreferencePrince M, Lester L, Chiniwala R, Berger B. Multitarget stool DNA tests increases colorectal cancer screening among previously noncompliant Medicare patients. World J Gastroenterol. 2017; 23: 464 ‐ 471.
dc.identifier.citedreferenceChubak J, Bogart A, Fuller S, Laing SS, Green BB. Uptake and positive predictive value of fecal occult blood tests: a randomized controlled trial. Prev Med. 2013; 57: 671 ‐ 678. doi: 10.1016/j.ypmed.2013.08.032
dc.identifier.citedreferenceRitvo P, Myers RE, Paszat L, Serenity M, Perez DF, Rabeneck L. Gender differences in attitudes impeding colorectal cancer screening. BMC Public Health. 2013; 13: 500.
dc.working.doi10.7302/141en
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
cncr33274.pdf
Size:
227.3KB
Format:
PDF
View/Open
Name:
cncr33274_am.pdf
Size:
288.9KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.